HD-OPM Archive
Hashtags

#heartfailure

41 posts

Urolithin A, a pomegranate gut metabolite, improved HFpEF in mice and human heart tissue

Aug 20, 2026 · Louis Nervegna ♥ 20 · 💬 9 Heart rhythm & heart failure

A Science Advances study from King's College London found that urolithin A activates the heart-protective protein PKGIα at cysteine 42, improving heart relaxation, fibrosis and exercise activity in mice with HFpEF and relaxing engineered human heart tissue. About half of people produce urolithin A from pomegranate; human trials are lacking, so benefit for patients is unproven.

Selenium plus CoQ10 trial: over 50% lower CV death, benefit persisted 10-12 years

Dec 18, 2023 · Louis Nervegna ♥ 14 · 💬 12 Supplements & vitamins

Louis reshares a post quoting Life Extension on a trial where older people took selenium plus coenzyme Q10 for four years and had more than half the cardiovascular mortality. Follow-up showed 49% lower CV death at 10 years and 41% at 12 years, including in subgroups with heart disease, diabetes and hypertension. He suggests adding about 200 ug selenium to CoQ10. The source is a supplement-company magazine and the trial is not named.

Selenium plus CoQ10 for 4 years halved CV mortality, with benefit lasting 12 years

Dec 03, 2023 · Louis Nervegna ♥ 9 · 💬 6 ↩ 2 Supplements & vitamins

Louis quotes a Life Extension article on a trial of older people taking selenium plus coenzyme Q10 for four years, with over 50% lower cardiovascular death. Follow-ups showed 49% lower CV death at 10 years and 41% at 12 years, persisting in subgroups with heart disease, diabetes and hypertension. Source is a supplement company magazine; the trial is not named.

Spermidine linked to lower mortality and cognitive decline, and longer lifespan in animals

Mar 16, 2024 · Gokhan Can ♥ 12 · 💬 4 Supplements & vitamins

Summarizes studies on spermidine, an autophagy-inducing polyamine: higher dietary intake is associated with lower all-cause mortality and cognitive decline in humans, and it extends lifespan in animal models. Natto, wheat germ, mushrooms, soy products and aged cheese are rich sources, and supplementation appears well tolerated in older adults.

Two FDA-approved antibiotics induced heart regeneration in mice and pigs after ischemia

Mar 21, 2024 · Louis Nervegna ♥ 22 · 💬 1 Heart rhythm & heart failure

Louis shares news that two FDA-approved antibiotics, paromomycin and neomycin, were identified in Hesham Sadek's lab at UT Southwestern as inducing cardiomyocyte proliferation. In adult mice and in pigs after cardiac ischemia/reperfusion injury, the combination improved left ventricular systolic function and decreased scar formation. This is preclinical animal work.

Rapamycin for 8 weeks improved diastolic and endothelial function in six older men

Oct 31, 2025 · Gokhan Can ♥ 7 · 💬 2 Aging & longevity

Summarises a proof-of-concept open-label pilot in six healthy men aged 70-76 taking rapamycin 1 mg daily for 8 weeks. It was safe and well tolerated; systolic function was unchanged but cardiac MRI showed better diastolic function (peak filling rate p=0.014) and endothelial function improved (p=0.020). Very small and uncontrolled; larger placebo-controlled trials are needed.

WOSCOPS 20-year follow-up: 5 years of pravastatin gave lasting mortality and event benefit

Apr 07, 2026 · Gokhan Can ♥ 7 · 💬 1 Statins

Describes the 20-year follow-up of the West of Scotland Coronary Prevention Study: 5 years of pravastatin in middle-aged men with high cholesterol and no prior CHD produced a lasting legacy effect, with reduced all-cause, CV and coronary mortality and fewer heart failure and MI hospitalizations. No excess cancer or non-CV mortality was seen.

Stem-cell heart patch (BioVAT) raised ejection fraction at 3 months in phase 1-2 trial

Jun 20, 2026 · Louis Nervegna ♥ 6 · 💬 1 Heart rhythm & heart failure

Louis shares a NEJM interim report of a phase 1-2 trial in which stem-cell-derived engineered tissue was placed on the surface of failing human hearts. At 3 months it was associated with thicker target heart wall, higher ejection fraction and better quality-of-life scores, though every patient had at least one adverse event and longer follow-up is needed.

Heart failure in 2026: SGLT2 inhibitors foundational, HFpEF now treatable, early GDMT

Mar 29, 2026 · Louis Nervegna ♥ 4 Heart rhythm & heart failure

A Cardiophilia summary of the latest heart failure evidence update lists several shifts: SGLT2 inhibitors are foundational across the ejection fraction spectrum, HFpEF now has options (finerenone, GLP-1 and incretin therapies), guideline therapy starts in-hospital, decongestion becomes guided by urine sodium, and devices are integrated into care.

Statins may lower cardiac embolism risk via pleiotropic effects; anticoagulants lead

Oct 24, 2026 · Louis Nervegna ♥ 2 · 💬 1 Statins

A quoted explainer says statins may reduce cardioembolic stroke risk via anti-inflammatory and endothelial effects, and preclinical data suggest protection against adverse heart remodeling. Anticoagulants remain the main defense in AFib, and clinical evidence on structural benefits is mixed. No specific studies are named.

mRNA-driven Myc and Cyclin T1 restarted heart muscle cell division after heart attack

Nov 14, 2026 · Louis Nervegna ♥ 2 Heart rhythm & heart failure

Louis shares a summary of a Nature Cardiovascular Research study from Cambridge using temporary modified mRNA to activate Myc and Cyclin T1 in heart muscle cells so mature cardiomyocytes re-enter division. The aim is to regenerate heart tissue after a heart attack instead of leaving scar tissue and chronic heart failure. This is early-stage regeneration research.